Cue Biopharma, Inc. · NASDAQ:CUE
Lin Shao-Lee received 327,537 Cue Biopharma, Inc. shares as an award (Form 4)
Traded May 3, 2026 · Filed May 7, 2026
On May 3, 2026, Lin Shao-Lee (Director, CHIEF EXECUTIVE OFFICER) received 327,537 Cue Biopharma, Inc. shares as an award, leaving 327,537 shares. Filed May 7, 2026 (Form 4).
- Awarded
- 327,537 shares
- Holding after
- 327,537 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 3, 2026 | Common Stock | Award | 327,537 | 327,537 | Direct |
Source
Related
- Cue Biopharma, Inc.
- Lin Shao-Lee
- Cue Biopharma, Inc. shareholders
- Form 4 · Lin Shao-Lee · Oct 14, 2026
- Form 4 · Lin Shao-Lee · Aug 14, 2026
- Form 4 · Lin Shao-Lee · Jul 10, 2026
- Form 4 · Ray Sumita · Oct 14, 2026
- Form 4 · Meluzio Michael Vincent · Oct 14, 2026
- Schedule 13G/A · Mark E. Strome · Oct 8, 2026
- Form 4/A · Sarraf Pasha · Aug 28, 2026
- Form 4/A · Garzone Pamela · Aug 28, 2026